Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table.

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

Per WSJ’s forecasting data, the average UNH price target is $378.86 per share. Given that the current UNH price is $292.80 ...

Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to ...

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $225.85? Let's take a closer look at the ...

The stakes of Hinge Health's investors and executives are now worth millions after the company debuted on the stock market.

What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 6.5% in the afternoon session after the Centers for ...

Bond yields inched higher and Wall Street flipped from small gains to losses before the opening bell Thursday after rising ...

Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to ...

Stocks are drifting on Wall Street Thursday following a rocky week so far because of worries coming out of the bond market ...

Key Takeaways U.S. equities edged higher at midday after the House passed the big tax and spending package supported by ...

Humana maintains a healthy balance sheet, in our opinion. Most of its cash and investments ($24 billion as of mid-2024) is held at its subsidiaries, though, and the company aims to hold about $500 ...